Karen Brunke
Director/Board Member at CYTODYN INC.
Net worth: - $ as of 2024-03-30
Profile
Karen J.
Brunke is an Independent Director at CytoDyn, Inc. and the Executive VP-Corporate & Business Development at Jaguar Health, Inc. She was previously the Chief Executive Officer at Cardeus Pharmaceuticals, Inc. Brunke received her undergraduate and doctorate degrees from the University of Pennsylvania.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CYTODYN INC.
-.--% | 2024-01-02 | 0 ( -.--% ) | - $ | 2024-03-30 |
Karen Brunke active positions
| Companies | Position | Start |
|---|---|---|
| JAGUAR HEALTH, INC. | Corporate Officer/Principal | 2021-09-08 |
| CYTODYN INC. | Director/Board Member | 2022-03-31 |
Former positions of Karen Brunke
| Companies | Position | End |
|---|---|---|
| Cardeus Pharmaceuticals, Inc. | Chief Executive Officer | - |
Training of Karen Brunke
| University of Pennsylvania | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| CYTODYN INC. | Health Technology |
| JAGUAR HEALTH, INC. | Health Technology |
| Private companies | 1 |
|---|---|
| Cardeus Pharmaceuticals, Inc. |
- Stock Market
- Insiders
- Karen Brunke
